Arrowhead Pharmaceuticals, Inc. today announced new results from the Phase 3 PALISADE study and the open-label extension from the Phase 2 MUIR and SHASTA-2 studies of investigational plozasiran. These ...

Treatment of hyperlipidemia Therapeutic lifestyle changes are an important component of hyperlipidemia treatment, since Type 2 diabetes mellitus, hypertension, obesity and physical inactivity are ...

identification and treatment of hyperlipidemia in all groups. Cite this: Hyperlipidemia in Racial/Ethnic Minorities: Differences in Lipid Profiles and the Impact of Statin Therapy - Medscape - Dec ...

On Tuesday, Nov. 5, as part of the Johns Hopkins Medicine’s Department of Neurology and Neurosurgery Neuroimmunology Seminar Series, Dr. Amber Salter delivered an overview of her ongoing work ...

Prioritising eye health through timely check-ups and proactive management is crucial for individuals with diabetes to ...

Arrowhead Pharmaceuticals, Inc. today announced that it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for investigational plozasiran for the treatment of ...

Nearly three decades later, drug makers have developed six approved small interfering RNA (siRNA) therapeutics in the ...

An Arkansas Legislative Council subcommittee has recommended that the state's health insurance plans for public school and ...

metabolic fatty liver disease', which has a high prevalence of about 30% in domestic adults, is a disease in which fat is deposited in the liver and is closel ...

we've been catching lots of hyperlipidemia, lots of high blood pressures. So those things, once we get on top of it, we can ...

Left atrial appendage closure is an alternative strategy for stroke prophylaxis, Wazni and colleagues noted. "The safety and ...

The following is a summary of “Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic ...